Braveheart Bio, Inc. ($BRVE)
Filing Information
| Accession Number | 0001470831-26-000799 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 7, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
301,111
Total Value
$19,998.00
P&L
+46027.3% (+$9,204,537.49)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer | Common Stock | โ | Aug 7, 2026 | Purchase | 1,111 | $18.00 | $19,998.00 | 332,161 | Direct | โ | View Details | |
Chief Development Officer | Stock Option (Right to Buy) | Derivative | Aug 5, 2026 | Grant/Award | 300,000 | $0.00 | $0.00 | 300,000 | Direct | โ | View Details |